Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | DOCN | CPAY |
|---|---|---|
| Price | $136.89 | $390.60 |
| Change today | ▲ 2.62% | ▲ 0.51% |
| Market cap | $16.10B | $25.65B |
| Return, 3 months | – | – |
| Return, year to date | – | – |
| Return, 1 year | – | – |
| P/E (TTM) | 62.2 | 23.8 |
| P/B | 17.3 | 7.2 |
| P/E percentile vs own 5y | – | 78th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +21.5% |
| Net profit growth (YoY) | – | -11.4% |
| Gross margin | – | 79.0% |
| Operating margin | – | 40.5% |
| Net margin | – | 22.7% |
| Return on equity | – | 30.5% |
| Analyst target vs. price | +28.6% | +20.9% |
| Analyst buy share | 86% | 83% |
| RSI (14) | – | – |
| 30-day volatility | – | – |
| Max drawdown, 1 year | – | – |
| Trend read | – | – |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
